The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of the study is to see that in addition to existing therapy, how well an additional procedure named spinal cord stimulation might reduce blood vessel spasm from aneurysm rupture.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Diagnosed with Fisher grade 3 or 4 aneurysmal subarachnoid hemorrhage (1)

Ability to undergo endovascular treatment of aneurysmal subarachnoid hemorrhage

Disqualifiers

Medically unfit to undergo endovascular treatment (e.g., Hunt Hess grade 5)

Does not provide consent for the procedure.

Posterior circulation aneurysmal subarachnoid hemorrhage.

Initial aneurysm treatment after post bleed day 1

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vectris trial leads and stimulation

    Device

    The electrode is placed into the epidural space using standard epidural placement techniques with paramedian approach. The initial electrode settings have been adopted from prior studies. Should any significant discomfort be elicited from the stimulation, first the amplitude will be decreased to an acceptable level. If an acceptable level of stimulation is unable to be found, the stimulation will be discontinued.

  • Sham

    Device

    No electrode is placed.

Treatment groups

25 Participants
are divided into 2 treatment groups
Group A: Spinal Cord StimulationExperimental treatment 1 intervention
Group B: Sham ComparatorSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pre-Cerebrovascular response - Velocity

Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.

Time frame
Day 1 - Day 14
2

Pre-Cerebrovascular response - Resistance

Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.

Time frame
Day 1 - Day 14
3

Pre-Cerebrovascular response - Lindegaard ratio

Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.

Time frame
Day 1 - Day 14
4

Post-Cerebrovascular response - Velocity

Post SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.

Time frame
Day 1 - Day 14

Secondary outcomes

1

Overall Survival

Overall survival is defined for all patients and measured from time of treatment to death or end of a study. The analyses for overall survival will be like that of the primary endpoint. It will also utilize Kaplan Meier methods and Cox proportional hazards modeling to compare the overall survival to the treatment-dependent prognosis index.

Time frame
Through study completion, approximately 24 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: